Secondaries announced 10.22.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Vital Therapies Symbol: VTL Price: Last trade $5.51 Trade Date: 10/23 Shares: 5.4 million Underwriter(s) BofA Merrill Lynch Rating=Subscription Needed
